Author

S. Chipurupalli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

N. Robinson· 2 shared R. Ganesan· 2 shared A. Antebi· 1 shared C. Calabrese· 1 shared D. Thomas· 1 shared E. Kannan· 1 shared G. Martini· 1 shared H. Nolte· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

N. Robinson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mitochondrial translocation of TFEB regulates complex I and inflammation

C. Calabrese, H. Nolte, M. R. Pitman, R. Ganesan, P. Lampe, R. Laboy, R. Ripa, J. Fischer, S. Chipurupalli, S. Gutierrez, R. Polara, D. Thomas, S. M. Pitson, A. Antebi, N. Robinson

This study shows TFEB regulates mitochondrial complex I and inflammation through non-transcriptional mechanisms, with implications for immune pathogenesis during infection.

bioRxiv · Feb 27, 2023Cell Biology

Cancer cells adapt FAM134B-BiP complex mediated ER-phagy to survive hypoxic stress

S. Chipurupalli, R. Ganesan, G. Martini, L. Mele, E. Kannan, V. Namasivayam, V. Desiderio, N. Robinson

This study shows cancer cells use the FAM134B-BiP complex to trigger ER-phagy under hypoxia, enabling survival, and identifies vitexin as a drug that blocks this process to inhibit breast cancer.

bioRxiv · Feb 5, 2021Cancer Biology